Top-News

Bioage Labs Aktie News

Aktie
WKN:  A40D7P ISIN:  US09077V1008 US-Symbol:  BIOA Branche:  Pharmazeutika Land:  USA
11,61 $
+1,11 $
+10,57%
9,9710 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
240,68 Mio. €
Streubesitz
27,79%
KGV
-2,92
Index-Zuordnung
-

Bioage Labs News

27.10.25 - wallstreetONLINE Redaktion
Kursrakete?: Diese Biotech-Aktie könnte sich durch neues Adipositas-Medikament verdoppeln
Citigroup traut BioAge Labs dank eines vielversprechenden Adipositas-​Medikaments deutliche Kurs­gewinne zu und hebt die Aktie mit verdoppeltem Ziel an.BioAge Labs steht laut ...
17.03.25 - PR Newswire
BioArctic receives Orphan Drug Designation for exidavnemab the US
BioArctic receives Orphan Drug Designation for exidavnemab the US PR Newswire
17.03.25 - PR Newswire
BioArctic receives Orphan Drug Designation for exidavnemab the US
BioArctic receives Orphan Drug Designation for exidavnemab the US PR Newswire
10.03.25 - PR Newswire
Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA
Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA PR Newswire
10.03.25 - PR Newswire
BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
10.03.25 - PR Newswire
BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR ...
10.03.25 - PR Newswire
BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
06.03.25 - PR Newswire
BIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit
BIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit PR Newswire
06.03.25 - PR Newswire
INVESTOR DEADLINE MONDAY: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIOA
INVESTOR DEADLINE MONDAY: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIOA PR Newswire
06.03.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
06.03.25 - PR Newswire
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire
05.03.25 - PR Newswire
BIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
05.03.25 - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs PR Newswire
04.03.25 - PR Newswire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
04.03.25 - PR Newswire
BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
03.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming Deadlines - BIOA PR ...
03.03.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
03.03.25 - PR Newswire
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BIOA
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BIOA PR Newswire
28.02.25 - PR Newswire
BioAge Labs, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
BioAge Labs, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit PR Newswire
28.02.25 - PR Newswire
BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire

Newssuche

Videos

newspaper
06.12.25
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
TempraMed Technologies Ltd
0,3605 €
-20,7%
TempraMed Technologies Ltd Chart
Das 1.000% Wachstum initiiert?!
Mehr zur Aktie »